- Page 1 and 2:
CORSO AVANZATO PER MEDICI Trattamen
- Page 3:
→ Il flusso ematico renale rappre
- Page 6 and 7:
Factors that render the kidney susc
- Page 8 and 9:
IRA: definizione L’IRA IRA è una
- Page 10 and 11:
Incidenza dell’IRA dell IRA (Vinc
- Page 12 and 13:
August 28-30, 28 30, 2000 New York
- Page 14 and 15:
ORIGINAL INVESTIGATIONS The Outcome
- Page 16 and 17:
Hospital Mortality Rate in RRT Pati
- Page 18 and 19:
• IRA,frequente complicanza in IC
- Page 20 and 21:
DIAGNOSES IN 544 PATIENTS WITH ARF
- Page 22 and 23:
Acute Renal Failure in critically i
- Page 24 and 25:
M.E. Ostermann, D. Taube, C.J. Morg
- Page 26 and 27:
A higher level of knowledge needs t
- Page 28 and 29:
Vivino G, Antonelli M, Moro ML, Cot
- Page 30 and 31:
Risk factors increased by • Age
- Page 32 and 33:
Agents and Events That Ameliorate o
- Page 34 and 35:
Drugs Associated with Acute Renal F
- Page 36 and 37:
RI=0.63 Renal Protection through st
- Page 38 and 39:
A.de Mendonça, J.L. Vincent, P.M.
- Page 40 and 41:
• Infection … they concluded th
- Page 42 and 43:
De Mendonça A et al. Acute renal f
- Page 44 and 45:
• Advanced age • Altered previo
- Page 46 and 47:
Quale forma di IRA è frequentement
- Page 48 and 49:
Sepsi: Stadi e definizioni Infezion
- Page 50 and 51:
Arterial Vasodilatation and Renal V
- Page 52 and 53:
Effect of Membrane Potential on the
- Page 54 and 55: good and bad effects of nitric oxid
- Page 56 and 57: FORMATION OF LPS/PROTEIN COMPLEXES
- Page 58 and 59: Tubular-Cell Injury and Repair in I
- Page 60 and 61: ACTIVATION OF HUMORAL PATHWAY L P S
- Page 62 and 63: A disorder due to incontrolled infl
- Page 64 and 65: The pathogenesis of septic acute re
- Page 66 and 67: Jo e colleghi hanno recentemente di
- Page 68 and 69: APOPTOSIS
- Page 70 and 71: Acute renal failure Norbert Lameire
- Page 73: 600 500 400 300 200 100 0 PaO2/FiO2
- Page 77 and 78: ml/die 8000 7000 6000 5000 4000 300
- Page 79 and 80: mg/dL 700 600 500 400 300 200 100 0
- Page 81 and 82: Lasciato a se stesso e non contrast
- Page 83 and 84: Strategie di protezione
- Page 85 and 86: SEPSI E IRA Rilascio citochine,atti
- Page 87 and 88: Renal Perfusion Pressure: Pressure
- Page 89 and 90: • Riempimento volemico per manten
- Page 91 and 92: Acute phase: Patients who have dila
- Page 93 and 94: Cardiovascular changes associated w
- Page 95 and 96: Dellinger RP. Crit Care Med 2003;31
- Page 97 and 98: Edema removal by a dialysis techniq
- Page 100: “independent independent from an
- Page 103: …..guardando gli effetti biologic
- Page 107 and 108: Terapia anti apoptosica? The Acute
- Page 109 and 110: (%) Survival Rate of Early Vs Late
- Page 112 and 113: EARLY ISOVOLEMIC HAEMOFILTRATION IN
- Page 114 and 115: - Trattamento extracorporeo del san
- Page 116 and 117: MOST Brain Liver mRNA/NfKb Cytokine
- Page 118 and 119: Early detection of ARF,especially i
- Page 120 and 121: . . Grazie per l’attenzione l att
- Page 122 and 123: The Response to Pathogens, Involvin
- Page 125 and 126: Immunologic Response of Three Hypot
- Page 127 and 128: Dal momento che la sepsi è un proc
- Page 129: IMMUNOMODULAZIONE : Il goal della M